Back

Evidence- and experience-based strategies of rapid LDL reduction in ACS.

18 March 2022 (17:25 - 17:40)
Organised by:
Congress Presentation Part of: Lipid management in patients with acute coronary syndrome: strike early and strong!! Lipid-Lowering Agents ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Professor Marc Claeys

University of Antwerp, Antwerp (Belgium)

3 More presentations in this session

Presentation thumbnail
How good/bad are we in achieving target LDLs post ACS?
Professor K. Kotseva (London, GB)
Slides Video
Presentation thumbnail
Optimal LDL management in clinical practise.
Doctor K. Krychtiuk (Vienna, AT)
Slides Video
Presentation thumbnail
Lipid Management in Patients with Acute Coronary Syndrome: strike early and strong!! - discussion.
Video

Access the full session

Session thumbnail
Lipid management in patients with acute coronary syndrome: strike early and strong!!
Video

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March 2022 17:25 CET
You may be interested in
thumbnail
Congress Presentation
LDL-cholesterol: the lower, the better - but also the sooner, the better!
14 March 2025
thumbnail
Congress Presentation
State-of-the-art lecture on impact of lipid and adipose tissue changes in acute coronary syndromes
30 August 2024
thumbnail
Congress Presentation
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
30 August 2024
thumbnail
Congress Presentation
Prevention starts at the intensive-care unit
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources